Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 19, 2023, titled "Sun Pharma Announces Health Canada Approval of PRWINLEVI�� (clascoterone cream 1%) for Topical Treatment of Acne".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 19, 2023, titled "Sun Pharma Announces Health Canada Approval of PRWINLEVI�� (clascoterone cream 1%) for Topical Treatment of Acne".